Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa

Revista Espanola de Enfermedades Digestivas

Volumn 95, Issue 2, 2003, Pages 97-104

  Jorge, O ^a   Cuello Carrion F D ^b   Jorge, A ^a   Ciocca, Daniel R ^b  

^a HOSPITAL ESPAÑOL DE MENDOZA   (Argentina)

^b INSTITUTO ARGENTINO DE NIVOLOGÍA   (Argentina)

Author keywords

Gastritis; Helicobacter pylori; Immunohistochemistry; Molecular markers

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; CYCLINE; LANSOPRAZOLE; MOLECULAR MARKER; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN P21; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL TRANSFORMATION; CHRONIC GASTRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; ENDOSCOPIC BIOPSY; EPITHELIUM CELL; ERADICATION THERAPY; FEMALE; GENE INACTIVATION; GENE MUTATION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOID CELL; MALE; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH MUCOSA;

ADOLESCENT; ADULT; AGED; BIOPSY; CHRONIC DISEASE; DATA INTERPRETATION, STATISTICAL; ENDOSCOPY; FEMALE; GASTRIC MUCOSA; GASTRITIS; GENES, BCL-2; GENES, ERBB-2; GENES, P53; GENETIC MARKERS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH; STOMACH NEOPLASMS; STOMACH ULCER;

EID: 0346033376     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Nardone G, Staibano S, Rocco A, Mezza E, D'armiento FP, Insabato L, et al. Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 1999; 44 (6): 789-99.
2. Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 1999; 13 Supl. 1: 3-11.
3. EUROGAST Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359-62.
4. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, et al. Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (Phila.) 1994; 73: 2691-4.
5. Cats A, Meuwissen SG, Forman D, Craanen ME, Kuipers EJ. Helicobacter pylori: a true carcinogen?. Eur J Gastroenterol Hepatol 1998; 10 (6): 447-50.
6. Kelly DJ. The physiology and metabolism of human gastric pathogen Helicobacter pylori. Adv Microb Physiol 1998; 40: 137-89.
7. Tsujii M, Kawano S, Tsujii T, et al. Ammonia: a possible promoter in Helicobacter pylori related gastric carcinogenesis. Cancer Lett 1992; 65: 15-8.
8. Drake IM, Mapstone NP, Schorach CJ, White KL, Chalmers DM, Dixon MF, et al. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H. pylori eradication. Gut 1998; 42 (6): 768-71.
9. Hahm KB, Lee KJ, Kim JH, Cho SW, Chung MH. Helicobacter pylori infection, oxidative damage, gastric carcinogenesis, and reversibility by rebamipide. Digestive Dis. Sci. 1998; 43 (Supl. 9): 72S-7S.
10. Barthel J, Everett E. Diagnosis of Campylobacter pylori infections: The "gold standard" and the alternatives. Rev Infect Dis 1990; 12: S107.
11. Ciocca DR, Bjercke RJ. Immunohistochemical techniques using monoclonal antibodies. In: Langone JJ, Van Vunakis E, eds. Methods Enzymol. Volume 121. Miami, FL: Academic Press, 1986. p. 562-79.
12. Elias JM, Margiotta M, Gaborc D. Sensitivity and detection efficiency of the peroxidase antiperoxidase (PAP), avidin-biotin peroxidase complex (ABC), and peroxidase-labeled avidin-biotin (LAB) methods. Am. J Clin Pathol 1989; 92: 62-7.
13. Shi S-R, Imam SA, Young L, Cote RJ, Taylor CR. Antigen retrieval immunohistochemistry under the influence of pH using monoclonal antibodies. J Histochem Cytochem 1995; 43: 193-201.
14. Wolf HK, Dittrich KL. Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 1992; 40: 1269-73.
15. Vojtesek B, Bontek J, Midgley CA. An immunochemical analysis of human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods 1992; 151: 237-44.
16. Vargas Roig LM, Lotfi H, Olcese JE, Lo Castro G, Ciocca DR. Effects short-term tamoxifen administration in patients with invasive cervical carcinoma. Anticancer Res 1993 ; 13: 2457-64.
17. Lee SH, Pan ZQ, Kwong AD, Burgers PMJ, Hurwitz J. Synthesis of DNA by DNA polymerase e in vitro. J Biol Chem 1991; 266: 22707-17.
18. Kelman Z. PCNA: structure, functions and interactions. Oncogene 1997; 14: 629-40.
19. Lynch DA, Clarke AM, Jackson P, Axon AT, Dixon MF, Quirke P. Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens. J Clin Pathol 1994; 47: 122-5.
20. Lynch DA, Mapstone NP, Clarke AM, Sobala GM, Jackson P, Morrison L, et al. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut 1995; 36: 346-50.
21. Chow KW, Bank S, Ahn J, Roberts J, Blumstein M, Kranz V. Helicobacter pylori infection does not increase gastric antrum mucosal cell proliferation. Am J Gastroenterol 1995; 90: 64-6.
22. Panella C, Ierardi E, Polimeno L, Balzabo T, Ingrosso M, Amoruso A, et al. Proliferative activity of gastric epithelium in progressive stages of Helicobacter pylori infection. Digestive Dis Sci 1996; 41: 1132-8.
23. Blaser MJ, Perez-Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increase risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55: 2111-5.
24. Fraser AG, Sim R, Sankey EA, Dhillon AP, Pounder RE. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment. Pharmacol Ther 1994; 8: 167-73.
25. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, et al. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 1993; 88: 1870-5.
26. Weinstein B. Mitogenesis is only one factor carcinogenesis. Science 1991; 251: 387-8.
27. Cho Y, Gorina S, Jeffrey PD, Pavletich NP. Crystal structure of a p53 tumor-suppresor-DNA complex: Understanding tumorogenic mutations. Science 1994; 265: 346-55.
28. Hongyo T, Buzard GS, Palli D, Weghorst CM, Amorosi A, Galli M, et al. Mutations of the K-ras and p53 in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res 1995; 55: 2665-72.
29. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, et al. Evaluation of immunoreactivity for c-erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 1991; 51: 1034-8.
30. Bronner MP, Culin C, Reed JC, Furth EE. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 1995; 146: 20-6.
31. Hengartner MO. The biochemistry of apoptosis. Nature 2000; 407: 770-6.
32. Pezzella T, Tse AGD, Cordell JL, Pullford KAF, Gatter KC, Mason DY. Expression of the bcl-2 oncogene protein is not specific for the 14:18 chromosome translocation. Am J Pathol 1990; 137: 225-32.
33. Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia E. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol 1994; 205 (Supl.): 11-21.
34. Bos JL. Ras oncogenes in human cancer: A review. Cancer Res 1989; 49: 4682-9.
35. Yu J, Zhang JK. Study on the association between Helicobacter pylori infection and the pathogenesis of gastric cancer by using molecular biological techniques. J Tongji Med Univ 1994; 14: 65-70.